Published in CA Cancer J Clin on September 18, 2012
Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer | NCT01856322
Native American ancestry affects the risk for gene methylation in the lungs of Hispanic smokers from New Mexico. Am J Respir Crit Care Med (2013) 1.54
Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion. Nucleic Acids Res (2013) 1.44
Retracted Up-regulation of pVHL along with down-regulation of HIF-1α by NDRG2 expression attenuates proliferation and invasion in renal cancer cells. PLoS One (2013) 1.40
Body mass index, age, and gender affect prep quality, sedation use, and procedure time during screening colonoscopy. Dig Dis Sci (2013) 1.38
The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression. J Hematol Oncol (2015) 1.09
Esophageal cancer: Recent advances in screening, targeted therapy, and management. J Carcinog (2014) 1.02
The influence of health disparities on targeting cancer prevention efforts. Am J Prev Med (2014) 0.98
Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study. PLoS One (2013) 0.97
Health disparities and cancer: racial disparities in cancer mortality in the United States, 2000-2010. Front Public Health (2015) 0.96
The impact of a culturally tailored patient navigator program on cervical cancer prevention in Latina women. J Womens Health (Larchmt) (2013) 0.95
FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma. J Cancer Res Clin Oncol (2013) 0.95
Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management. Front Oncol (2015) 0.95
Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells. Int J Biol Sci (2015) 0.92
Feasibility of cold snare polypectomy in Japan: A pilot study. World J Gastrointest Endosc (2015) 0.90
Understanding the patient-provider communication needs and experiences of Latina and non-Latina White women following an abnormal mammogram. J Cancer Educ (2014) 0.89
Interplay between genomic alterations and androgen receptor signaling during prostate cancer development and progression. Horm Cancer (2013) 0.89
Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase. Mol Cancer (2013) 0.89
Concurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer. Onco Targets Ther (2015) 0.89
Factors associated with breast cancer in Puerto Rican women. J Epidemiol Glob Health (2013) 0.87
A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma. Gynecol Oncol (2014) 0.86
A human papillomavirus vaccination program for low-income postpartum women. Am J Obstet Gynecol (2016) 0.86
Hispanic accrual on randomized cancer clinical trials: a call to arms. J Clin Oncol (2014) 0.85
Religious beliefs and cancer screening behaviors among Catholic Latinos: implications for faith-based interventions. J Health Care Poor Underserved (2014) 0.84
Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence? World J Urol (2014) 0.84
Time to definitive diagnosis of breast cancer in Latina and non-Hispanic white women: the six cities study. Springerplus (2013) 0.84
The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective. Breast Cancer Res Treat (2015) 0.83
ER-α36-mediated gastric cancer cell proliferation via the c-Src pathway. Oncol Lett (2013) 0.83
Recurrent inactivating RASA2 mutations in melanoma. Nat Genet (2015) 0.83
Histone methyltransferase SETDB1 is required for prostate cancer cell proliferation, migration and invasion. Asian J Androl (2014) 0.83
Bevacizumab and ovarian cancer. Ther Adv Med Oncol (2013) 0.83
miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1. Biomed Res Int (2015) 0.83
Adenoma Prevalence and Distribution Among US Latino Subgroups Undergoing Screening Colonoscopy. Dig Dis Sci (2016) 0.83
Knowledge, attitudes, and beliefs about human papillomavirus (HPV) vaccination among Puerto Rican mothers and daughters, 2010: a qualitative study. Prev Chronic Dis (2014) 0.82
Glycyrrhetinic Acid triggers a protective autophagy by activation of extracellular regulated protein kinases in hepatocellular carcinoma cells. J Agric Food Chem (2014) 0.82
A meta-analysis of the relationship between RARβ gene promoter methylation and non-small cell lung cancer. PLoS One (2014) 0.82
Gemifloxacin, a fluoroquinolone antimicrobial drug, inhibits migration and invasion of human colon cancer cells. Biomed Res Int (2013) 0.82
Intergenerational transmission of the effects of acculturation on health in Hispanic Americans: a fetal programming perspective. Am J Public Health (2015) 0.82
GOLPH3L is a Novel Prognostic Biomarker for Epithelial Ovarian Cancer. J Cancer (2015) 0.82
Physician and Family Recommendations to Obtain a Mammogram and Mammography Intentions: The Moderating Effects of Perceived Seriousness and Risk of Breast Cancer. J Womens Health Care (2014) 0.82
Metastasis to the Thyroid Gland: A Critical Review. Ann Surg Oncol (2016) 0.81
Psychological distress, social withdrawal, and coping following receipt of an abnormal mammogram among different ethnicities: a mediation model. Oncol Nurs Forum (2014) 0.81
Advances in cancer immunotherapy. Discov Med (2013) 0.81
Role of RUNX3 in suppressing metastasis and angiogenesis of human prostate cancer. PLoS One (2014) 0.81
Heterogeneity in periodontitis prevalence in the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol (2014) 0.81
UBE3C promotes growth and metastasis of renal cell carcinoma via activating Wnt/β-catenin pathway. PLoS One (2015) 0.81
The Association of Coronary Artery Calcium With Noncardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis. JACC Cardiovasc Imaging (2016) 0.81
Are cancer-related decision aids appropriate for socially disadvantaged patients? A systematic review of US randomized controlled trials. BMC Med Inform Decis Mak (2016) 0.81
HOI-02 induces apoptosis and G2-M arrest in esophageal cancer mediated by ROS. Cell Death Dis (2015) 0.80
Synthesis of liver-targeting dual-ligand modified GCGA/5-FU nanoparticles and their characteristics in vitro and in vivo. Int J Nanomedicine (2013) 0.80
Viruses, Other Pathogenic Microorganisms and Esophageal Cancer. Gastrointest Tumors (2015) 0.79
Loss of autophagy-related protein Beclin 1 may define poor prognosis in ovarian clear cell carcinomas. Int J Oncol (2015) 0.79
Is the Expression of Androgen Receptor Protein Associated With the Length of AC Repeats in the Type III 5-α Reductase Gene in Prostate Cancer Patients? Korean J Urol (2013) 0.79
A favourable prognostic marker for EGFR mutant non-small cell lung cancer: immunohistochemical analysis of MUC5B. BMJ Open (2015) 0.79
Decreased Cancer Mortality-to-Incidence Ratios with Increased Accessibility of Federally Qualified Health Centers. J Community Health (2015) 0.79
Religion, fatalism, and cancer control: a qualitative study among Hispanic Catholics. Am J Health Behav (2014) 0.79
Health disparities in colorectal cancer among racial and ethnic minorities in the United States. J Gastrointest Oncol (2016) 0.79
Retention of black and white participants in the selenium and vitamin E cancer prevention trial (SWOG-coordinated intergroup study S0000). Cancer Epidemiol Biomarkers Prev (2014) 0.78
Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes. Cancer Epidemiol Biomarkers Prev (2013) 0.78
Characterization of the novel tumor-suppressor gene CCDC67 in papillary thyroid carcinoma. Oncotarget (2016) 0.78
Blockade of MK2 is protective in inflammation-associated colorectal cancer development. Int J Cancer (2015) 0.78
Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS). J Neural Transm (Vienna) (2013) 0.78
Role of Natural Stilbenes in the Prevention of Cancer. Oxid Med Cell Longev (2015) 0.78
Upregulation of miR-1280 expression in non-small cell lung cancer tissues. Chin Med J (Engl) (2015) 0.78
Anti-tumor effect of β-glucan from Lentinus edodes and the underlying mechanism. Sci Rep (2016) 0.78
Trends in cancer screening by citizenship and health insurance, 2000-2010. J Immigr Minor Health (2015) 0.78
Using Genetic Technologies To Reduce, Rather Than Widen, Health Disparities. Health Aff (Millwood) (2016) 0.77
Frequency of SMN1 deletion carriers in a Mestizo population of central and northeastern Mexico: A pilot study. Exp Ther Med (2015) 0.77
The descriptive epidemiology of gastric cancer in Central America and comparison with United States Hispanic populations. J Gastrointest Cancer (2015) 0.77
Patient navigation to increase colorectal cancer screening among Latino Medicare enrollees: a randomized controlled trial. Cancer Causes Control (2015) 0.77
Racial and Ethnic Variations in Lung Cancer Incidence and Mortality: Results From the Women's Health Initiative. J Clin Oncol (2015) 0.76
Antimetastatic activity of novel ruthenium (III) pyridine complexes. Cancer Med (2016) 0.76
Association of serum lipid levels and prostate cancer severity among Hispanic Puerto Rican men. Lipids Health Dis (2015) 0.76
In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells. Br J Pharmacol (2014) 0.76
Mechanisms by Which Pleiotropic Amphiphilic n-3 PUFA Reduce Colon Cancer Risk. Curr Colorectal Cancer Rep (2014) 0.76
The expression of tumor-derived and stromal-derived matrix metalloproteinase 2 predicted prognosis of ovarian cancer. Int J Gynecol Cancer (2015) 0.76
Family/friend recommendations and mammography intentions: the roles of perceived mammography norms and support. Health Educ Res (2015) 0.76
Increased expression of tumor proliferation genes in Hispanic women with early-stage breast cancer. Cancer Invest (2014) 0.76
Red meat, poultry, and fish intake and breast cancer risk among Hispanic and Non-Hispanic white women: The Breast Cancer Health Disparities Study. Cancer Causes Control (2016) 0.76
Relationship between serum CA19-9 and CEA levels and prognosis of pancreatic cancer. Ann Transl Med (2015) 0.76
Self-Reported Cancer Prevalence among Hispanics in the US: Results from the Hispanic Community Health Study/Study of Latinos. PLoS One (2016) 0.75
Long-term recovery of normal sexual function in testicular cancer survivors. Asian J Androl (2015) 0.75
Optical coherence tomography accurately identifies patients with penile (pre) malignant lesions: A single center prospective study. Urol Ann (2015) 0.75
Gastric adenocarcinoma: clinicopathologic differences among Hispanics and non-Hispanic whites. A single Institution's experience over 14 years. Ann Gastroenterol (2016) 0.75
Perceived discrimination and cancer screening behaviors in US Hispanics: the Hispanic Community Health Study/Study of Latinos Sociocultural Ancillary Study. Cancer Causes Control (2016) 0.75
Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma. World J Gastroenterol (2015) 0.75
Disparities in cervical cancer survival among Asian-American women. Ann Epidemiol (2015) 0.75
HPV Knowledge Among a Marginalized Population [Letter]. Prev Chronic Dis (2013) 0.75
Expression of Chemokine XCL2 and CX3CL1 in Lung Cancer. Med Sci Monit (2016) 0.75
Anal cancer trends in Puerto Rico from 1985 to 2005: the potential impact of the AIDS epidemic. AIDS Patient Care STDS (2014) 0.75
Trend Analysis of Cancer Mortality and Incidence in Panama, Using Joinpoint Regression Analysis. Medicine (Baltimore) (2015) 0.75
Clinical and pathological characteristics of Hispanic BRCA-associated breast cancers in the American-Mexican border city of El Paso, TX. Am J Cancer Res (2014) 0.75
Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): a randomized trial in obese endometrial cancer survivors. Contemp Clin Trials (2014) 0.75
Standardized cancer incidence disparities in Upper Manhattan New York City neighborhoods: the role of race/ethnicity, socioeconomic status, and known risk factors. Eur J Cancer Prev (2016) 0.75
Metastatic breast cancer presenting as a gallstone ileus. J Surg Case Rep (2013) 0.75
Improving cancer clinical research and trials with Hispanic populations: training and outreach efforts between Moffitt Cancer Center and the Ponce School of Medicine. Rev Recent Clin Trials (2014) 0.75
Racial/Ethnic Differences Affecting Adherence to Cancer Screening Guidelines Among Women. J Womens Health (Larchmt) (2015) 0.75
Ubiquitin-specific protease 7 expression is a prognostic factor in epithelial ovarian cancer and correlates with lymph node metastasis. Onco Targets Ther (2016) 0.75
Ovarian xenobiotic biotransformation enzymes are altered during phosphoramide mustard-induced ovotoxicity. Toxicol Sci (2014) 0.75
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin (2011) 30.81
Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin (2012) 14.47
Colorectal cancer statistics, 2014. CA Cancer J Clin (2014) 12.86
Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin (2004) 12.55
Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin (2014) 11.09
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36
International variation in prostate cancer incidence and mortality rates. Eur Urol (2012) 8.04
Breast cancer statistics, 2013. CA Cancer J Clin (2013) 7.35
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst (2003) 7.06
Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer (2007) 6.84
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol (2012) 6.37
Experiences of discrimination: validity and reliability of a self-report measure for population health research on racism and health. Soc Sci Med (2005) 6.14
Breast cancer statistics, 2011. CA Cancer J Clin (2011) 6.12
Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer (2002) 6.08
Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin (2007) 5.67
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer (2009) 5.55
Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin (2007) 5.31
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
Cancer mortality in the United States by education level and race. J Natl Cancer Inst (2007) 4.77
Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin (2006) 4.73
Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer (2006) 4.71
Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71
International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev (2009) 4.49
Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer (2013) 4.24
Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin (2012) 4.13
The global burden of cancer: priorities for prevention. Carcinogenesis (2009) 3.73
Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin (2014) 3.59
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55
Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev (2009) 3.08
Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med (2005) 3.02
Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst (2006) 2.66
Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol (2011) 2.58
Cancer statistics for African Americans. CA Cancer J Clin (2002) 2.45
Cancer statistics for African Americans, 2013. CA Cancer J Clin (2013) 2.44
International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev (2011) 2.40
Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev (2012) 2.39
Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst (2002) 2.38
Trends in breast cancer by race and ethnicity. CA Cancer J Clin (2004) 2.19
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial. Hepatology (2006) 2.06
Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidemiol Biomarkers Prev (2011) 2.06
Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology (2008) 2.02
Tobacco control in the United States--recent progress and opportunities. CA Cancer J Clin (2009) 1.97
The influence of sex, race/ethnicity, and educational attainment on human immunodeficiency virus death rates among adults, 1993-2007. Arch Intern Med (2012) 1.92
Cancer statistics for Hispanics, 2003. CA Cancer J Clin (2003) 1.88
Recent trends in Black-White disparities in cancer mortality. Cancer Epidemiol Biomarkers Prev (2008) 1.86
Pancreatic cancer death rates by race among US men and women, 1970-2009. J Natl Cancer Inst (2013) 1.85
Incidence of noncutaneous melanomas in the U.S. Cancer (2005) 1.85
How much of the decrease in cancer death rates in the United States is attributable to reductions in tobacco smoking? Tob Control (2006) 1.80
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut (2010) 1.78
Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C. Gastroenterology (2006) 1.73
DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial. J Hepatol (2008) 1.71
State disparities in colorectal cancer mortality patterns in the United States. Cancer Epidemiol Biomarkers Prev (2011) 1.54
Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C. Gastroenterology (2010) 1.52
Trends in the incidence of colorectal cancer in relation to county-level poverty among blacks and whites. J Natl Med Assoc (2008) 1.42
A new method of predicting US and state-level cancer mortality counts for the current calendar year. CA Cancer J Clin (2004) 1.42
Management trends in stage I testicular seminoma: Impact of race, insurance status, and treatment facility. Cancer (2014) 1.41
Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev (2012) 1.36
Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001. J Natl Cancer Inst (2008) 1.34
A new method of estimating United States and state-level cancer incidence counts for the current calendar year. CA Cancer J Clin (2007) 1.33
Trends in colorectal cancer incidence rates by age, race/ethnicity, and indices of access to medical care, 1995–2004 (United States). Cancer Causes Control (2009) 1.33
Cancer incidence patterns among adolescents and young adults in the United States. Cancer Causes Control (2005) 1.25
Widening socioeconomic disparities in cervical cancer mortality among women in 26 states, 1993-2007. Cancer (2012) 1.21
Association of cutaneous melanoma incidence with area-based socioeconomic indicators-United States, 2004-2006. J Am Acad Dermatol (2011) 1.20
Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006. J Am Acad Dermatol (2011) 1.20
Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995 to 1999. Cancer Epidemiol Biomarkers Prev (2004) 1.19
Body mass index in young adulthood and premature death: analyses of the US National Health Interview Survey linked mortality files. Am J Epidemiol (2011) 1.15
Disparities in breast cancer prognostic factors by race, insurance status, and education. Cancer Causes Control (2010) 1.15
Predicting US- and state-level cancer counts for the current calendar year: Part II: evaluation of spatiotemporal projection methods for incidence. Cancer (2012) 1.14
Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006. Cancer Epidemiol Biomarkers Prev (2010) 1.12
Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades. Cancer (2013) 1.11
Temporal trends in breast cancer mortality by state and race. Cancer Causes Control (2008) 1.11
Age-specific trends in black-white disparities in cervical cancer incidence in the United States: 1975-2009. Gynecol Oncol (2012) 1.05
Insurance status is related to diffuse large B-cell lymphoma survival. Cancer (2014) 1.04
Interpreting cancer trends. Ann N Y Acad Sci (2006) 1.03
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial. Gastroenterology (2009) 1.03
Social disparities in the burden of occupational exposures: results of a cross-sectional study. Am J Ind Med (2007) 1.02
U.S. congressional district cancer death rates. Int J Health Geogr (2006) 1.00
Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis. Clin Gastroenterol Hepatol (2008) 0.96
Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C. Gastroenterology (2011) 0.95
Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010-2011). Breast Cancer Res Treat (2014) 0.95
Work-to-family spillover and fruit and vegetable consumption among construction laborers. Am J Health Promot (2007) 0.95
The rise and fall of cancer mortality in the USA: why does pancreatic cancer not follow the trend? Future Oncol (2013) 0.95
AACR Cancer Progress Report 2013. Clin Cancer Res (2013) 0.95
Cancer-related risk factors and preventive measures in US Hispanics/Latinos. CA Cancer J Clin (2012) 0.95
Trends in colorectal cancer screening with home-based fecal occult blood tests in adults ages 50 to 64 years, 2000-2008. Cancer (2012) 0.94